Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up (UPC)

April 21, 2026 updated by: Stryker Craniomaxillofacial

Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up to Confirm Safety and Performance

A retrospective post market follow up to confirm safety and performance of Stryker's Facial iD Universal Plate Configurator (UPC) implants in the clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Study Overview

Detailed Description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Facial iD UPC plating system when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. Based on a non-inferiority study power calculation a minimum of 80 patients will be enrolled in the study. Additional patients may be enrolled up to 800 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States will participate in this study. The primary outcome parameter evaluating successful fixation or reconstruction of the midface without the need for unplanned revision surgery will be evaluated at all available follow-up timepoints of the included patients.

Study Type

Observational

Enrollment (Estimated)

726

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10022
        • New York Center for Orthognathic and Maxillofacial Surgery
      • New York, New York, United States, 11042
        • New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, New York

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

Description

Inclusion Criteria:

  1. Patients who received a Stryker UPC plate for osteotomy, stabilization and rigid fixation of maxillofacial fractures or reconstruction as per routine clinical practice
  2. Patients for whom data on the primary outcome variable is available.

Exclusion Criteria:

  1. Patients with non-reducible and unstable fractures at the time of surgery
  2. Patients with fractures of a severely atrophic mandible at the time of surgery
  3. Patients with active local infections at the time of surgery
  4. Patients with metal allergies and/or foreign body sensitivity at the time of surgery
  5. Patients with limited blood supply or insufficient quality or quantity of bone at the time of surgery
  6. Potentially non-compliant patients who are unwilling or incapable of following postoperative care instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Successful fixation or reconstruction of the midface without the need for unplanned revision surgery.
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.
Data collected at a single time point per patient in the course of 18 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infection rate
Time Frame: Data collected at time points from patient medical charts in the course of 18 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points from patient medical charts in the course of 18 months.
Intraoperative complications
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Determined by adverse events reported from patient medical charts.
Data collected at a single time point per patient in the course of 18 months.
Postoperative complications
Time Frame: Data collected at time points per patient in the course of 18 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points per patient in the course of 18 months.
Any known adverse events
Time Frame: Data collected at time points per patient in the course of 18 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points per patient in the course of 18 months.
Plate failure
Time Frame: Data collected at time points point per patient in the course of 18 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points point per patient in the course of 18 months.
Satisfactory occlusion achieved after additional orthodontic treatment
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Data reported in patient medical charts
Data collected at a single time point per patient in the course of 18 months.
Time to return to solid food/normal diet
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Time for patient to return to solid food/normal diet post operation (dd)
Data collected at a single time point per patient in the course of 18 months.
Hospitalization time; ICU and normal ward
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Time the patient was hospitalized post procedure (dd:hh)
Data collected at a single time point per patient in the course of 18 months.
EuroQol-5 Domain Questionnaire (if available)
Time Frame: Data collected at time points per patient in the course of 18 months.
A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).
Data collected at time points per patient in the course of 18 months.
Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)
Time Frame: Data collected at time points per patient in the course of 18 months.
40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.
Data collected at time points per patient in the course of 18 months.
12-Item Short Form Health Survey (SF-12)
Time Frame: Data collected at time points per patient in the course of 18 months.
12 items grouped and scored to produce two separate summary scores: the Physical Component Summary (PCS-12) and the Mental Component Summary (MCS-12). The scale is transformed to a 0-100 range with higher scores indicating better health.
Data collected at time points per patient in the course of 18 months.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary indication for the surgery / diagnosis
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Diagnosis collected from patient medical charts.
Data collected at a single time point per patient in the course of 18 months.
Max follow-up time
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Maximum post operative follow up time for patients within standard of care. Reported in patient medical charts during hospital follow up visits.
Data collected at a single time point per patient in the course of 18 months.
Surgical approach
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Surgical approach taken for the procedure. Including: transoral; intraoral; maxillary vestibular approach; transbuccal; submandibular; preauricular; other
Data collected at a single time point per patient in the course of 18 months.
Medical conditions
Time Frame: Data collected at time points point per patient in the course of 18 months.
Underlying medical conditions and medication that may be related to the device or primary outcome.
Data collected at time points point per patient in the course of 18 months.
Localization of the defect
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Area to treated by the device: mandibular ramus; mandibular body; mandibular condyle; parasymphysis; paramedian; Le Fort I; Le Fort II; Le Fort III; others
Data collected at a single time point per patient in the course of 18 months.
Post operative maxillo-mandibular fixation
Time Frame: Data collected at a single time point per patient in the course of 18 months.
For patients that receive maxillo-mandibular fixation post operation the length of time after surgery the fixation procedure took place (days).
Data collected at a single time point per patient in the course of 18 months.
Patient Radiation Exposure
Time Frame: Data collected at time points per patient in the course of 18 months.

Exposure of patient to radiation therapy within 12 months around the surgery date recorded in patient medical charts (number and type of radiation procedures performed).

Radiation therapy performed on the anatomical area treated with the device.

Any postoperative radiation therapy recorded in patient medical charts.

Data collected at time points per patient in the course of 18 months.
Sterilization method used
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Sterilization method used for the device. Qualitative responses from site.
Data collected at a single time point per patient in the course of 18 months.
Fixation system used
Time Frame: Data collected at a single time point per patient in the course of 18 months.
System used to fix the device during the procedure. Stryker Universal CMF screws; others
Data collected at a single time point per patient in the course of 18 months.
Tightening of screws
Time Frame: Data collected at a single time point per patient in the course of 18 months.

Tools used to fix the device during the procedure. Response options include :

Manual and electric screw driver

Data collected at a single time point per patient in the course of 18 months.
Orthognathic cases
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Usage of splints in orthognathic cases.
Data collected at a single time point per patient in the course of 18 months.
Year smoking was stopped
Time Frame: Data collected at time points per patient in the course of 18 months.
Year smoking was stopped (YYYY)
Data collected at time points per patient in the course of 18 months.
Smoking frequency
Time Frame: Data collected at time points per patient in the course of 18 month
The frequency of exposure to smoking during periods of smoking (average number of cigarettes per day).
Data collected at time points per patient in the course of 18 month
Smoking duration
Time Frame: Data collected at time points per patient in the course of 18 month
Duration of smoking (pack years)
Data collected at time points per patient in the course of 18 month
Years of active smoking
Time Frame: Data collected at time points per patient in the course of 18 month
Total number of years active smoker (YY)
Data collected at time points per patient in the course of 18 month
Patient weight
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Weight (kg, lb)
Data collected at a single time point per patient in the course of 18 months.
Patient height
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Height (cm, feet, inches)
Data collected at a single time point per patient in the course of 18 months.
Patient age
Time Frame: Data collected at a single time point per patient in the course of 18 months.
Age (years)
Data collected at a single time point per patient in the course of 18 months.
Gender
Time Frame: Data collected at a single time point per patient in the course of 18 months
Responses: Male, Female, undifferentiated, unknown
Data collected at a single time point per patient in the course of 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 18, 2024

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Study Registration Dates

First Submitted

August 1, 2025

First Submitted That Met QC Criteria

November 17, 2025

First Posted (Actual)

November 24, 2025

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mandibular Fractures

Clinical Trials on Orthognatic surgery, Reconstructive maxillofacial surgery, Mandible and maxillofacial trauma surgery

Subscribe